Angiotensin system inhibitors and survival in patients with metastatic renal cell carcinoma treated with VEGF-targeted therapy: A pooled secondary analysis of clinical trials.

Angiotensin system inhibitors and survival in patients with metastatic renal cell carcinoma treated with VEGF-targeted therapy: A pooled secondary analysis of clinical trials.

Item
http://www.wikidata.org/entity/Q41035635
Hypertension and Angiotensin System Inhibitors in Patients with Metastatic Renal Cell CarcinomaDo renin-angiotensin system inhibitors influence the recurrence, metastasis, and survival in cancer patients?: Evidence from a meta-analysis including 55 studiesUp-Regulation of Angiotensin-Converting Enzyme (ACE) Enhances Cell Proliferation and Predicts Poor Prognosis in Laryngeal CancerRenin angiotensin system deregulation as renal cancer risk factor.Use of inhibitors of the renin-angiotensin system is associated with longer survival in patients with hepatocellular carcinoma.Targeting the renin-angiotensin system to improve cancer treatment: Implications for immunotherapy.Assessment of pazopanib-related hypertension, cardiac dysfunction and identification of clinical risk factors for their development.
P2860

Angiotensin system inhibitors and survival in patients with metastatic renal cell carcinoma treated with VEGF-targeted therapy: A pooled secondary analysis of clinical trials.

Item
http://www.wikidata.org/entity/Q41035635
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Angiotensin system inhibitors ...... y analysis of clinical trials.
@en
type
label
Angiotensin system inhibitors ...... y analysis of clinical trials.
@en
prefLabel
Angiotensin system inhibitors ...... y analysis of clinical trials.
@en
P1433
P1476
P2093
P2860
P304
P31
P356
P433
P478
P50
P577
P698
P356
P1433
P1476
Angiotensin system inhibitors ...... ry analysis of clinical trials
@en
P2093
P2860
P304
P31
P356
P433
P478
P50
P577
P698